Cargando…

Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT

OBJECTIVES: Preclinical and clinical studies suggested cardioprotective effects of metformin treatment. In the GIPS-III trial, 4 months of metformin treatment did not improve left ventricular ejection fraction in patients presenting with ST-elevation myocardial infarction (STEMI). Here, we report th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartman, Minke H. T., Prins, Jake K. B., Schurer, Remco A. J., Lipsic, Erik, Lexis, Chris P. H., van der Horst-Schrivers, Anouk N. A., van Veldhuisen, Dirk J., van der Horst, Iwan C. C., van der Harst, Pim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696505/ https://www.ncbi.nlm.nih.gov/pubmed/28755285 http://dx.doi.org/10.1007/s00392-017-1140-z

Ejemplares similares

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
por: Eppinga, Ruben N., et al.
Publicado: (2016)

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
por: Lexis, Chris P. H., et al.
Publicado: (2012)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial
por: Posma, Rene A., et al.
Publicado: (2015)

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
por: Al Ali, Lawien, et al.
Publicado: (2016)

Predictors of left ventricular remodeling after ST-elevation myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2017)

Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
por: Groot, Hilde E., et al.
Publicado: (2018)

Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction
por: Bouma, Wobbe, et al.
Publicado: (2016)

Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015)

Sex‐Based Differences in Unrecognized Myocardial Infarction
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
por: Al Ali, Lawien, et al.
Publicado: (2023)

Long-term outcome of elderly out-of-hospital cardiac arrest survivors as compared with their younger counterparts and the general population
por: Hiemstra, Bart, et al.
Publicado: (2018)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis
por: van der Ende, M. Yldau, et al.
Publicado: (2021)

Left ventricular restoration devices post myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2018)

Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS)
por: de Koning, Marie-Sophie L. Y., et al.
Publicado: (2020)

Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019)

Development and first results of a dedicated chronic total occlusion programme
por: van der Werf, H. W., et al.
Publicado: (2019)

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
por: Said, M. Abdullah, et al.
Publicado: (2018)

The effect of feedback on cardiovascular risk factors on optimization of primary prevention: The PharmLines initiative
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Case-finding of dementia in general practice and effects of subsequent collaborative care; design of a cluster RCT
por: van den Dungen, Pim, et al.
Publicado: (2012)

The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus
por: Lexis, Chris PH, et al.
Publicado: (2009)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

Case Finding of Mild Cognitive Impairment and Dementia and Subsequent Care; Results of a Cluster RCT in Primary Care
por: van den Dungen, Pim, et al.
Publicado: (2016)

Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

Author Correction: Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study
por: Groot, Hilde E., et al.
Publicado: (2020)

Metformin and lactic acidosis during shock: just the tip of the iceberg?
por: Posma, Rene A., et al.
Publicado: (2016)

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
por: van der Boom, Trynke, et al.
Publicado: (2021)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?
por: Ties, Daan, et al.
Publicado: (2022)

Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism
por: van der Plas, Willemijn Y., et al.
Publicado: (2016)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Heart Rehabilitation in patients awaiting Open heart surgery targeting to prevent Complications and to improve Quality of life (Heart-ROCQ): study protocol for a prospective, randomised, open, blinded endpoint (PROBE) trial
por: Hartog, Johanneke, et al.
Publicado: (2019)

Successful surgical excision of primary right atrial angiosarcoma
por: Bouma, Wobbe, et al.
Publicado: (2011)

Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
por: van der Harst, Pim, et al.
Publicado: (2018)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pud3shauojk5l3rcq9021lmt0d